Literature DB >> 25054746

Quality of life and self-esteem in patients submitted to surgical treatment of skin carcinomas: long-term results.

Paula Curitiba Maciel1, Joel Veiga-Filho1, Marcelo Prado Carvalho1, Fernando Elias Martins Fonseca1, Lydia Masako Ferreira2, Daniela Francescato Veiga1.   

Abstract

BACKGROUND: Cancer is a multifactorial disease and skin carcinomas are the most common type of cancer. Assessing quality of life and self-esteem outcomes in skin cancer patients is important because these are indicators of the results of the treatment, translating how patients face their lives and their personal relationships.
OBJECTIVE: To assess the late impact of the surgical treatment of head and/or neck skin carcinomas on quality of life and self-esteem of the patients.
METHODS: Fifty patients with head or neck skin carcinomas were enrolled. Their age ranged between 30 and 75 years, 27 were men and 23 were women. Patients were assessed with regard to quality of life and self-esteem, preoperatively and five years postoperatively. Validated instruments were used: the MOS 36-item Short-form Health Survey (SF-36) and the Rosenberg Self-esteem/EPM-UNIFESP Scale. The Wilcoxon signed-rank test was used for the statistical analysis.
RESULTS: Twenty-two patients completed the five-year follow-up, 54.5% women and 45.5% men. Compared to the preoperative assessment, patients had an improvement in mental health (p=0.011) and in self-esteem (p=0.002). There was no statistical difference with regard to the other domains of the SF-36.
CONCLUSION: Patients submitted to surgical treatment of skin carcinoma improved mental health and self-esteem in the late postsurgical testing.

Entities:  

Mesh:

Year:  2014        PMID: 25054746      PMCID: PMC4148273          DOI: 10.1590/abd1806-4841.20142742

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  13 in total

Review 1.  Quality of life as an outcome measure in surgical oncology.

Authors:  B S Langenhoff; P F Krabbe; T Wobbes; T J Ruers
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  [Quality of life evaluation in cancer patients to submitted to chemotherapy].

Authors:  Namie Okino Sawada; Adriana Cristina Nicolussi; Liyoko Okino; Fernanda Mara Coelho Cardozo; Marcia Maria Fontão Zago
Journal:  Rev Esc Enferm USP       Date:  2009-09       Impact factor: 1.086

3.  An estimate of the cost of treating non-melanoma skin cancer in the state of São Paulo, Brazil.

Authors:  Reynaldo José Sant'Anna Pereira de Souza; Adriana P Mattedi; Marcelo P Corrêa; Marcelo L Rezende; Ana Cláudia Andrade Ferreira
Journal:  An Bras Dermatol       Date:  2011 Jul-Aug       Impact factor: 1.896

4.  The validity and practicality of sun-reactive skin types I through VI.

Authors:  T B Fitzpatrick
Journal:  Arch Dermatol       Date:  1988-06

5.  Predictors of quality of life in patients with skin melanoma at the dermatology department of the Porto Alegre Teaching Hospital.

Authors:  Mariana Tremel Barbato; Lucio Bakos; Renato Marchiori Bakos; Rita Prieb; Cláudia Dickel de Andrade
Journal:  An Bras Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.896

6.  Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Arch Facial Plast Surg       Date:  2006 Sep-Oct

7.  [Skin cancer: use of preventive measures and demographic profile of a risk group in the city of Botucatu].

Authors:  Regina Célia Popim; José Eduardo Corrente; Jaqueline Aparecida Geromel Marino; Carolina Arantes de Souza
Journal:  Cien Saude Colet       Date:  2008 Jul-Aug

8.  Dimensioning the fear of dermatologic diseases.

Authors:  Mariana Álvares Penha; Pamela Medeiros dos Santos; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2012 Sep-Oct       Impact factor: 1.896

9.  The impact of nasal reconstruction following tumour resection on psychosocial functioning, a clinical-empirical exploration.

Authors:  Sanne E Moolenburgh; Marc A M Mureau; Sarah L Versnel; Hugo J Duivenvoorden; Stefan O P Hofer
Journal:  Psychooncology       Date:  2009-07       Impact factor: 3.894

10.  Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5 year review.

Authors:  Pedro Andrade; Maria Manuel Brites; Ricardo Vieira; Angelina Mariano; José Pedro Reis; Oscar Tellechea; Américo Figueiredo
Journal:  An Bras Dermatol       Date:  2012 Mar-Apr       Impact factor: 1.896

View more
  5 in total

1.  Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports.

Authors:  Robabeh Abedini; Maryam Nasimi; Pedram Noormohammad Pour; Atie Moghtadaie; Hamid Reza Tohidinik
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

2.  Responsiveness of the Spanish Version of the "Skin Cancer Index".

Authors:  M de Troya-Martín; F Rivas-Ruiz; N Blázquez-Sánchez; I Fernández-Canedo; M Aguilar-Bernier; J B Repiso-Jiménez; J C Toribio-Montero; M Jones-Caballero; J Rhee
Journal:  J Skin Cancer       Date:  2016-10-09

3.  Analysis of the Skin Basocellular Carcinoma (BCC) Among the Smokers in Bosnia and Herzegovina.

Authors:  Darko Lukic; Reuf Karabeg; Vildana Jahic; Andrea Stanojevic; Biljana Pavlovska; Zoran Krickovic; Goran Predojevic; Dusko Ivic; Ivana Gajic
Journal:  Mater Sociomed       Date:  2018-12

4.  Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry.

Authors:  Aleksandar Sekulic; Simon Yoo; Ragini Kudchadkar; Julie Guillen; Gary Rogers; Anne Lynn S Chang; Scott Guenthner; Bernard Raskin; Keith Dawson; Yong Mun; Laura Chu; Edward McKenna; Mario Lacouture
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

5.  Burden of Itch in Patients with Basal Cell Carcinoma.

Authors:  Iwona Chlebicka; Aleksandra A Stefaniak; Łukasz Matusiak; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2021-07-30       Impact factor: 3.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.